NBI-3001

· Neurocrine Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NBI-3001, covering 2013-07-18 to 2013-07-18. Get the full timeline:

Most recent: Clinical Trial Update: NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 2]